Geron Gets Shareholder Action Over Cancer Drug Trimmed
A California federal judge on Friday trimmed a consolidated proposed shareholder class action accusing Geron Corp. of improperly touting the prospects of its cancer drug imetelstat before the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article